Brief: Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
14/05/2024 12:32
May 14 (Reuters) - Pliant Therapeutics Inc PLRX.O :
* PLIANT THERAPEUTICS ANNOUNCES POSITIVE TOPLINE DATA FROM A
PHASE
2A COLLAGEN PET IMAGING CLINICAL TRIAL OF BEXOTEGRAST IN
PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
* PLIANT THERAPEUTICS- IMPROVEMENT IN FVC & REDUCTION IN
COUGH
SEVERITY REPORTED IN BEXOTEGRAST-TREATED PATIENTS AT ALL
TIMEPOINTS COMPARED TO PLACEBO
Source text for Eikon: ID:nGNXKnYJQ
Further company coverage: PLRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals